Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
26/05/2026 15:31
BRIEF-Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees May 26 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS:
ASTRAZENECA PHARMA INDIA LTD MARCH-QUARTER PAT 448.8 MILLION RUPEES
ASTRAZENECA PHARMA INDIA LTD MARCH-QUARTER REVENUE FROM OPERATIONS 5.79 BILLION RUPEES
Further company coverage: ASTR.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication